An interventional study of Targeted Memory Reactivation (TMR) in Stroke, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 21 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-27.
Sponsored by Northwestern University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Stroke by Northwestern University — 6 open to participants now, 8 under way, none of them phase 3. Stroke · Northwestern University.
Among the 24 studies in Stroke by Northwestern University, this one is the 8th largest by planned enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2020, is one of 17 with no phase, and was the 18th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →6 of the 24 studies in Stroke by Northwestern University are open now, in 1 country. Recruiting first, the newest first:
Northwestern University · Sites in United States
Ages 18–85
Northwestern University · Sites in United States
Ages 18–80 · Healthy volunteers
Northwestern University · Sites in United States
Ages 18+ · Healthy volunteers
Northwestern University · Sites in United States
Ages 21+
Northwestern University · Sites in United States
Ages 18–80
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 21 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 70 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 52 across the 20 interventional studies, 104 across the 4 observational. Of the 15 that completed or were terminated, 6 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
2 of the studies in Stroke by Northwestern University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04312269Northwestern UniversityCombining MyoCI With Memory Reactivation to Improve Motor Recovery After Stroke | 2027-01-30 |
| NCT03401762Northwestern UniversityWearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 24 studies in Stroke by Northwestern University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will examine the combination of myoelectric computer interface (MyoCI) training with targeted memory reactivation (TMR) in chronic stroke survivors. The study aims to determine whether this training-plus-sleep combination will generalize to improve arm motor function over an extended training protocol in stroke survivors.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
TMR during every stage of sleep
Other: Targeted Memory Reactivation (TMR)
TMR during slow-wave sleep only
Other: Targeted Memory Reactivation (TMR)
TMR during only subset of sessions
Other: Targeted Memory Reactivation (TMR)
Patients receive no TMR
Other: Targeted Memory Reactivation (TMR)
Targeted memory reactivation (TMR) refers to the process of playing audio cues associated with specific learned material quietly during sleep in order to strengthen consolidation of specific memories during sleep.
Wolf Motor Function Test (WMFT)
The WMFT evaluates upper extremity function on a continuous scale. It measures the time it takes to perform 15 different tasks, with a time limit of 120 s per task.
Time frame: change from baseline at 6 weeks
Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function
The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.
Time frame: change from baseline at 6 weeks
Fugl-Meyer Assessment of Upper Extremity (UE) Motor Function
The FMA-UE is a measure of impairment. Maximum score is 66 on the motor function portion. Items are scored on a 3-point ordinal scale.
Time frame: change from baseline at 10 weeks
Motor Activity Log (MAL)
The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.
Time frame: change from baseline at 6 weeks
Motor Activity Log (MAL)
The MAL is a validated measure of home-based arm function, both quantity and quality of use in 30 different activities of daily living.
Time frame: change from baseline at 10 weeks
Modified Ashworth Scale
The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.
Time frame: change from baseline at 6 weeks
Modified Ashworth Scale
The Modified Ashworth Scale is a measure of spasticity, which is graded on a scale of 0-4 per joint tested.
Time frame: change from baseline at 10 weeks
Plan to share: Yes — Clinical functional outcomes and analyzed EMG (co-activation) will be uploaded and shared upon publication.
Supporting information: Analytic code
Time frame: IPD and associated analytic code will be made available upon publication of research results and will remain available for the duration of the funded project.
No publications or documents are linked to this record.
Started Feb 2020 (actual). Primary completion is estimated for Jan 2027, 83 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 83 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.